Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach

E-ISSN： 2212-3873|13|1|38-50

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.13, Iss.1, 2013-03, pp. : 38-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenosine therapy: a new approach to chronic heart failure

By Kitakaze M. Hori M.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2519-2535

Informa Healthcare

Access to resources Recommend Favorite

Thyroid Disorders in Chronic Heart Failure: From Prognostic Set-up to Therapeutic Management

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 1, 2013-03 ,pp. : 22-37

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic patents for chronic heart failure: a review of patent applications from 1996 to 2002

By Anker Stefan D Jankowska Ewa A Okonko Darlington O

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 639-654

Informa Healthcare

Access to resources Recommend Favorite

Inflammation and Chronic Heart Failure: From Biomarkers to Novel Anti-inflammatory Therapeutic Strategies

Medicinal Chemistry, Vol. 10, Iss. 7, 2014-11 ,pp. : 682-699

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Introduction to the Special Issue: Relevance of Endocrine and Metabolic Disorders in Heart Failure: From Pathophysiology to Therapeutic Approach)

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 1, 2013-03 ,pp. : 2-3

Bentham Science Publishers

Access to resources Recommend Favorite